NCT06818396 Analgesic Efficacy of Fascia Iliaca Compartment Block Compared With Intrathecal Nalbuphine for Hip Surgery Under Spinal Anesthesia
| NCT ID | NCT06818396 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Postoperative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-02-18 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-02-18 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is already known that fascia iliaca compartment block and intrathecal nalbuphine are very effective ways in postoperative pain control in patients having hip surgeries.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) score (ASA I- ASA II). * Age ≥ 21years. * Body mass index \< 35 kg/m2 Exclusion Criteria: * Patient's refusal. * Known coagulopathy. * Known peripheral neuropathy or neurological deficits. * Known allergy to study drugs
Frequently Asked Questions
Who can join the NCT06818396 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06818396 currently recruiting?
Yes, NCT06818396 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ain Shams University to inquire about joining.
Where is the NCT06818396 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06818396 clinical trial?
NCT06818396 is sponsored by Ain Shams University. The trial plans to enroll 120 participants.